An eye care company has reported $5.1 billion in revenue, with one investor increasing their stake. The company's earnings and outlook appear to be under scrutiny, with some outlets discussing its valuation and prospects. However, it is unclear how these developments will impact the company's overall performance, as other unrelated business news is also being reported.